About 60-80% of CCs develop on the basis of a dysregulation of the Wnt/β-catenin signalling pathway triggered in most cases by mutations in the tumour suppressor gene APC (adenomatous polyposis coli) which is indicated by an accumulation of β-catenin in the tumour cells [2-6]. This evidence concerns the gene APC and neoplasm.